252 related articles for article (PubMed ID: 2769330)
61. [PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Matsumoto H; Yonemura Y; Kosaka T; Muraoka K; Kaji M; Nakai M; Tsugawa K; Segawa M; Fushida S; Takano Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2227-30. PubMed ID: 1444489
[TBL] [Abstract][Full Text] [Related]
62. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA
Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
[TBL] [Abstract][Full Text] [Related]
63. Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.
Preusser P; Wilke H; Achterrath W; Fink U; Neuhaus P; Meyer J; Meyer HJ; van de Loo J
Recent Results Cancer Res; 1988; 110():198-206. PubMed ID: 3406503
[No Abstract] [Full Text] [Related]
64. [Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer].
Terata N; Sano H; Ishibashi H; Tani T; Hanasawa K; Endo Y; Kurumi Y; Shibata J; Kodama M; Tsuji K
Gan To Kagaku Ryoho; 1993 Apr; 20(5):611-6. PubMed ID: 8470918
[TBL] [Abstract][Full Text] [Related]
65. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.
Yoshikawa T; Sasako M; Yamamoto S; Sano T; Imamura H; Fujitani K; Oshita H; Ito S; Kawashima Y; Fukushima N
Br J Surg; 2009 Sep; 96(9):1015-22. PubMed ID: 19644974
[TBL] [Abstract][Full Text] [Related]
66. [A case of gastric carcinoma with peritonitis carcinomatosa responding remarkably to etoposide, adriamycin and cisplatin (EAP) therapy].
Inaba Y; Chiba M; Watabe S; Kudo K; Hayashi K; Otsuka S
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2421-3. PubMed ID: 1463349
[TBL] [Abstract][Full Text] [Related]
67. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
68. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
[TBL] [Abstract][Full Text] [Related]
69. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
70. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
71. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
72. [Adjuvant chemotherapy in gastric cancer. Experience at the National Institute of Nutrition].
León Rodríguez E; Domínguez A
Rev Invest Clin; 1992; 44(2):221-7. PubMed ID: 1439310
[TBL] [Abstract][Full Text] [Related]
73. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
74. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
75. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.
Ajani JA; Mansfield PF; Lynch PM; Pisters PW; Feig B; Dumas P; Evans DB; Raijman I; Hargraves K; Curley S; Ota DM
J Clin Oncol; 1999 Aug; 17(8):2403-11. PubMed ID: 10561303
[TBL] [Abstract][Full Text] [Related]
76. Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Cascinu S; Labianca R; Graziano F; Pancera G; Barni S; Frontini L; Luporini G; Cellerino R; Catalano G
Br J Cancer; 1998 Aug; 78(3):390-3. PubMed ID: 9703289
[TBL] [Abstract][Full Text] [Related]
77. New developments in the treatment of gastric carcinoma.
Wilke H; Preusser P; Fink U; Achterrath W; Mayer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Gerlings H
Cancer Treat Res; 1991; 55():363-73. PubMed ID: 1681867
[TBL] [Abstract][Full Text] [Related]
78. Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.
Lévi F; Benavides M; Chevelle C; Le Saunier F; Bailleul F; Misset JL; Regensberg C; Vannetzel JM; Reinberg A; Mathé G
J Clin Oncol; 1990 Apr; 8(4):705-14. PubMed ID: 2179481
[TBL] [Abstract][Full Text] [Related]
79. Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma.
Sutton GP; Stehman FB; Einhorn LH; Roth LM; Blessing JA; Ehrlich CE
J Clin Oncol; 1989 Feb; 7(2):223-9. PubMed ID: 2915238
[TBL] [Abstract][Full Text] [Related]
80. Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: a prospective randomised trial.
Popov I; Jelić S; Radulović S; Radosavljević D; Nikolić-Tomasević Z
Ann Oncol; 2000 Mar; 11(3):343-8. PubMed ID: 10811503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
